C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/18/2002	CN1385525A Precursor gene of frontal spot wasp calmative peptide, its coded polypeptide and preparation process
12/18/2002	CN1385441A Novel human lymphokine, its coding sequence and use
12/18/2002	CN1385440A Protein molecule with function for inhibiting I type simple herpesvirus replication and its preparation method
12/18/2002	CA2388761A1 Wound healing biomarkers
12/17/2002	US6496887 SRAM bus architecture and interconnect to an FPGA
12/17/2002	US6495844 Metal halide lamp for curing adhesives
12/17/2002	US6495742 Stress tolerant plants; genetic engineering
12/17/2002	US6495736 Compositions and methods for increasing bone mineralization
12/17/2002	US6495735 Transgenic non-human mammals expressing DNA sequences encoding homologous complement restriction factors of a discordant mammalian species
12/17/2002	US6495674 Nucleic acid encoding polypeptide with pleckstrin homology-and hydrophobic-binding domains; neurobiology; vesicle trafficking proteins
12/17/2002	US6495673 Expression library produced by mutagenesis
12/17/2002	US6495668 Isolated protein comprising a first polypeptide disulfide-bonded to a second polypeptide, wherein each of said first and second polypeptides is from 113 to 138 amino acid residues in length and comprises amino acid residues 258-370
12/17/2002	US6495667 Il-b30 antibodies
12/17/2002	US6495666 Polypeptide composing human chimeric antibody
12/17/2002	US6495665 Isoforms of mouse serotonin 5-HT2C receptor
12/17/2002	US6495664 Fluorescent protein sensors of post-translational modifications
12/17/2002	US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
12/17/2002	US6495661 Isolated nucleic acid molecule encoding the outer membrane protein of pasteurella multocida is provided. also provided are methods to detect the presence of the nucleic acid molecule, and antibodies specific for the polypeptide encoded
12/17/2002	US6495526 Inhibitors of cell-cycle progression and uses related thereto
12/17/2002	US6495520 Apoptosis Inducing Molecule II and methods of use
12/17/2002	US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002	US6495518 Method for importing biologically active molecules into cells
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495515 Inhibiting inflammation mediated by infiltrating macrophages; polypeptide having at least 50% amino acid sequence no:4 homology and biological function of myxoma t7 interferon gamma receptor
12/17/2002	US6495513 Morphogen-enhanced survival and repair of neural cells
12/17/2002	US6495376 Phosphoserine and phosphothreonine binding modules. the ww-domain containing polypeptides of the invention can be used, for example, to regulate cell growth; to treat neurodegenerative diseases; to screen for substances that
12/17/2002	US6495360 Increasing production yield of viruses, viral proteins, and other related biological materials through enhanced control and stabilization of protein production via stress proteins; permissive eukaryotic cell lines
12/17/2002	US6495356 Beryllofluoride analogues of acyl phosphate polypeptides
12/17/2002	US6495349 Chimeric gene constructs
12/17/2002	US6495348 Mitomycin biosynthetic gene cluster
12/17/2002	US6495347 Determining if fusion protein stimulates a th1-like response in cell sample; fusion proteins and conjugates that contain at least a portion of a heat shock protein; response detected by measuring interferon (ifn)-gamma produced by the cell sample
12/17/2002	US6495346 Do not react with foreign partners; amino acids inserted into proteins which naturally form dimers, mutated proteins only form complexes with themselves (homodimers) or with the mutated partner (heterodimers), not with nonmutated starting
12/17/2002	US6495345 Surface antigen
12/17/2002	US6495344 Useful in the nutrition of patients suffering from phenylketonuria
12/17/2002	US6495343 Cloning and recombinant production of CRF receptor(s)
12/17/2002	US6495339 Method of identifying a compound that modulates XAF-mediated apoptosis
12/17/2002	US6495335 Monitoring using adduct of amyloid protein modified with malonaldehyde
12/17/2002	US6495334 Reacting a sample obtained from poultry with a truncated sef14 antigen to permit anti-salmonella enteritidis antibodies to bind antigen; presence of antibody/antigen binding complex indicates infection
12/17/2002	US6495331 Regulation of cytokine production such that allergic inflammation is thereby treated by administering a compound which interacts with mekk/jnkk signal transduction pathway
12/17/2002	US6495322 Said protein induces apoptosis or is capable of generating or selecting an antibody to claimed amino acid sequence
12/17/2002	US6495145 LktA deletion mutant of P. haemolytica
12/17/2002	US6495144 A peptide having substantial homology with the cbf1/rbpjk (cell binding factor-1/recombination bining protein j kappa) interaction domain of ebna2 comprising specific peptide containing 15-20 amino acids
12/17/2002	US6495143 Inducing immunology response
12/17/2002	US6495139 Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
12/17/2002	US6495138 PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
12/17/2002	US6495136 Proteases having modified amino acid sequences conjugated to addition moieties
12/17/2002	US6495129 Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
12/17/2002	US6495128 Human chemokine β-7 deletion and substitution proteins
12/17/2002	CA2217700C A method of detecting biologically active substances
12/17/2002	CA2214439C A novel growth factor and a genetic sequence encoding same
12/17/2002	CA2174031C Benzoyl peroxide compositions
12/17/2002	CA2108977C Luteinizing hormone releasing hormone antagonist peptides
12/17/2002	CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
12/17/2002	CA2051010C Human luteinizing hormone-chorionic gonadotropin receptor protein, dna and use thereof
12/17/2002	CA2021722C Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices
12/17/2002	CA1341411C Method for producing fv fragments in eukaryotic cells
12/17/2002	CA1341410C Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
12/17/2002	CA1341409C Cloning and expression of htlv-iii dna
12/13/2002	CA2349040A1 Isolated carotenoid biosynthesis gene cluster involved in canthaxanthin production and application thereof
12/12/2002	WO2002099387A2 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
12/12/2002	WO2002099136A1 Methods and compositions fir identifying episomal dna virus infection treatment
12/12/2002	WO2002099132A1 Method of analyzing transcriptional regulatory domain
12/12/2002	WO2002099120A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002	WO2002099119A2 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002	WO2002099117A2 Nucleic acid regulatory sequences and uses therefor
12/12/2002	WO2002099116A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002099110A1 Cell cycle regulatory factor
12/12/2002	WO2002099108A2 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	WO2002099107A2 Regulation of human trace amine receptor ta5
12/12/2002	WO2002099106A2 Regulation of human secretin -type gpcr
12/12/2002	WO2002099104A1 Polypeptide unstabilizing protein in cells under aerobic conditions and dna encoding the same
12/12/2002	WO2002099103A1 Novel genes and proteins encoded thereby
12/12/2002	WO2002099102A1 Numb protein expression inhibitors by musashi
12/12/2002	WO2002099101A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002	WO2002099085A2 Human secreted proteins
12/12/2002	WO2002099084A2 Composite binding polypeptides
12/12/2002	WO2002099082A2 Expression of spider silk proteins in higher plants
12/12/2002	WO2002099079A2 Cytokinin response regulators and uses thereof
12/12/2002	WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins
12/12/2002	WO2002099076A2 Sugar and lipid metabolism regulators in plants ii
12/12/2002	WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002099072A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof
12/12/2002	WO2002099067A2 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
12/12/2002	WO2002099066A2 20 human secreted proteins
12/12/2002	WO2002099062A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002099039A2 Peptides for chlamydophila pneumoniae vaccine and diagnosis
12/12/2002	WO2002099037A2 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002	WO2002099036A2 Inhibition of neurodegeneration
12/12/2002	WO2002099035A2 Chimeric alphavirus replicon particles
12/12/2002	WO2002098920A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002	WO2002098919A2 Method for apo ciii measurement in apob and non apob containing particles
12/12/2002	WO2002098918A2 Novel targets for a therapeutic intervention in ebv related diseases
12/12/2002	WO2002098917A2 Human proteins and nucleic acids encoding same
12/12/2002	WO2002098916A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002	WO2002098915A2 Compositions and methods for detecting or regulating cholesteryl ester transfer protein
12/12/2002	WO2002098914A2 Mutants of igf binding proteins and methods of production of antagonists thereof

1 ... 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 ... 2916